Happy holidays!
From all of us at Arche Consulting: Merry Xmas & Happy New Year!
From all of us at Arche Consulting: Merry Xmas & Happy New Year!
One year ago the Note for Guidance ‘Implementing the concept of biocidal product family’ was put into force. This new family concept has forced everyone to reevaluate the way Biocidal Product Families are formed. The narrowed BPF concept and the subsequent stricter eCa’s [...]
Join the 9th edition of our online BPR Symposium covering different subjects and speakers over a period of 14 days, a fortnight. This new formula gives you the opportunity to keep an optimal focus over the different subjects and provides [...]
The current state of ecological risk assessment (ERA) considers the assessment of effects in standardized toxicity tests for single substances on individual organisms. However, in the environment, chemicals are rarely found alone, and not individual organisms are exposed but populations [...]
The adaptation of the EU Chemical Strategy for Sustainability (CSS) is a first step towards a zero pollution ambition for a toxic-free environment as announced in the European Green Deal. This new piece of legislation reshapes the world in which [...]
Manufacturers and formulators of biocidal products are faced with an ever growing burden to maintain the compliance of their products. Increasingly complicating regulatory requirements are affecting budget and time to market. Authorising your products in a consortium can help decrease these burdens as [...]
The Biocidal Products Committee adopted the opinion of BKC/ADBAC (Benzalkonium chloride - CAS 68424-85-1) and DDAC (Didecyldimethylammonium chloride - CAS 7173-51-5) for Product Type 3 and 4. All companies interested in placing new products or keeping existing products on the [...]
Biocidal products are authorized under Regulation (EU) No 528/2012 where it is imperative to prove that the products used are effective but do not at the same time elicit other undesirable effects on the target organisms such as increased resistance. However, currently there are no guidelines for the assessment of such undesired side-effects. In response, the [...]
Dr. Sabine Navis will be one of the key presenters at Chemical Watch’s annual Biocides Europe Conference on 1 and 2 December 2020 in Copenhagen. Dr. Navis will present our online endocrine disruptor screening tool “EDScreener” (developed in close collaboration [...]
The Belgian authorities have published an official communication concerning extension of the temporary authorizations that were granted during the initial weeks of the outbreak of corona virus. Products with a temporary authorization that contain an AS that is still under [...]